Guidelines for the Early Management of Patients with Ischemic Stroke
Stroke 34:1056-1083, Adams,H.P.,et al, 2003
Frequency of Thrombolytic Therapy in Patients With Acute Ischemic Stroke and the Risk of In-Hospital Mortality
Stroke 34:1106-1113, Heuschmann,P.U.,et al, 2003
Thrombolysis for Acute Stroke in Routine Clinical Practice
Arch Int Med 162:1994-2001, Bravata,D.M.,et al, 2002
Late Secondary Ischemic Injury in Patients Receiving Intraarterial Thrombolysis
Ann Neurol 52:698-703,695, Kidwell,C.S.,et al, 2002
Safety of Tissue Plasminogen Activator for Acute Stroke in Menstruating Women
Stroke 33;2506-2508, Wein,T.H.,et al, 2002
Analysis of the Safety and Efficacy of Intra-Arterial Thrombolytic Therapy in Ischemic Stroke
Stroke 33:2866-2870, Lisboa,R.C.,et al, 2002
Direct Percutaneous Transluminal Angioplasty for Acute Middle Cerebral Artery Trunk Occlusion
Stroke 33:2872-2876, Nakano,S.,et al, 2002
Magnetic Resonance Imaging Detection of Microbleeds Before Thrombolysis
Stroke 33:95-98, Kidwell,C.S.,et al, 2002
Clinical and Sonographic Patterns of Tandem Internal Carotid Artery/Middle Cerebral Artery Occlusion in Tissue Plasminogen Activator-Treated Patients
Stroke 33:99-102, El-Mitwalli,A.,et al, 2002
Acute Intravenou-Intra-Arterial Revascularization Therapy for Severe Ischemic Stroke
Stroke 33:279-282, Hill,M.D.,et al, 2002
Thrombolysis in Stroke Beyond Three Hours: Targeting Patients With Diffusion and Perfusion MRI
Ann Neurol 51:11-13,28, Warach,S., 2002
Changes in Blood Flow and Oxygen Metabolism During Visual Stimulation in Carotid Artery Disease
Stroke 33:1294-1300, Yamauchi,H.,et al, 2002
Acute Basilar Artery Occlusion Treated with Combined Intravenous Abciximab and Intra-arterial Tissue Plaminogen Activator
Stroke 33:1424-1427, Eckert,B.,et al, 2002
Thrombolytic Therapy Within 3 to 6 Hours After Onset of Ischemic Stroke
Stroke 33:1437-1441, Ringleb,P.A.,et al, 2002
Predictors of Hemorrhagic Transformation in Patients Receiving Intra-Arterial Thrombolysis
Stroke 33:717-724, Kidwell,C.S.,et al, 2002
Recent Developments in Neurology
BMJ 324:656-660, Wiebe,S.,&Nicolle,M.W., 2002
Thrombolysis in Patients with Acute Stroke Caused by Cervical Artery Dissection
Arch Neurol 59:549-553, Arnold,M.,et al, 2002
Magnetic Resonance Imaging in Basilar Artery Occlusion
Arch Neurol 59:398-402, du Mesnil de Rochemont,R.,et al, 2002
Alteplase for Stroke: Money and Optimistic Claims Buttress the "Brain Attack" Campaign
BMJ 324:723-729, Lenzer,J., 2002
Thrombolysis-Related Hemorrhagic Infarction
Stroke 33:1551-1556,1446, Molina,C.A.,et al, 2002
Prognostic Accuracy of Cerebral Blood Flow Measurement by Perfusion Computed Tomography, at the Time of Emergency Room Admission, in Acute Stroke Patients
Ann Neurol 51:417-432,415, Wintermark,M.,et al, 2002
Computed Tomographic Findings in Patients Undergoing Intra-arterial Thrombolysis for Acute Ischemic Stroke Due to Middle Cerebral Artery Occlusion
Stroke 33:1557-1567, Roberts,H.C.,et al, 2002
Clinical and Vascular Outcome in Internal Carotid Artery Versus Middle Cerebral Artery Occlusions After Intravenous Tissue Plasminogen Activator
Stroke 33:2066-2071, Linfante, I.,et al, 2002
Comparison of Admission Perfusion Computed Tomography and Qualitative Diffusion- and Perfusion-Weighted Magnetic Resonance Imaging in Acute Stroke Patients
Stroke 33:2025-2031, Wintermark,M.,et al, 2002
Predictors of Hemorrhagic Transformation After Intravenous Recombinant Tissue Plasminogen Activator
Stroke 33:2047-2052, Selim,M.,et al, 2002
Intra-Arterial Thrombolysis in 100 Patients With Acute Stroke Due to Middle Cerebral Artery Occlusion
Stroke 33:1828-1833, Arnold,M.,et al, 2002
Intracerebral Hemorrhages Associated with Neurointerventional Procedures Using a Combination of Antithrombotic Agents Including Abciximab
Stroke 33:1916-1919, Qureshi,A.I.,et al, 2002
Response of Intra-Arterial and Combined Intravenous and Intra-Arterial Thrombolytic Therapy in Patients with Distal Internal Carotid Artery Occlusion
Stroke 33:1821-1826,1827, Zaidat,O.O,et al, 2002
Anticoagulants and Antiplatelet Agents in Acute Ischemic Stroke
Neurol 59:13-22, Coull,B.M.,et al, 2002
Signs of Acute Stroke Seen on Fluid-Attenuated Inversion Recovery MR Imaging
AJR 179:237-243, Makkat,S.,et al, 2002
Admission Glucose Level and Clinical Outcomes in the NINDS rt-PA Stroke Trial
Neurol 59:669-674, Bruno,A.,et al, 2002
Arterial Reocclusion in Stroke Patients Treated with Intravenous Tissue Plasminogen Activator
Neurol 59:862-867, Alexandrov,A.V. &Grotta,J.C., 2002
Prognosis of Central Retinal Artery Occlusion:Local Intraarterial Fibrinolysis versus Conservative Treatment
AJNR 23:1301-1307, Schmidt,D.P.,et al, 2002
Baseline Blood Pressure but Not Early Computed Tomography Changes Predicts Major Hemorrhage After Streptokinase in Acute Ischemic Stroke
Stroke 33:22236-2242, Gilligan,A.K.,et al, 2002
Complete Recovery After Early Intraarterial Recombinant Tissue Plasminogen Activator Thrombolysis of Carotid T Occlusion
AJNR 23:1596-1599, Rabinstein,A.A., et al, 2002
Diffusion-perfusion MRI Characterization of Post-recanalization Hyperperfusion in Humans
Neurol 57:2015-2021, Kidwell,C.S.,et al, 2001
Thrombolysis in Patients with Transient Neurologic Deficits
Neurol 57:2125-2128, Lyden,P.,et al, 2001
Thrombolytic Therapy in Acute Ischemic Stroke Patients With Cardiac Thrombus
Neurol 57:2122-2125, Derex,L.,et al, 2001
Intraarterial Thrombolysis: Ready for Prime Time?
AJNR 22:55-58, Executive Committee of the ASITN, 2001
Delay in Presentation and Evaluation for Acute Stroke
Stroke 32:63-69, Lacy,C.R.,et al, 2001
Protocol Violations in Community-Based rTPA Stroke Treatment Are Associated with Symptomatic Intracerebral Hemorrhage
Stroke 32:12-16, Lopez-Yunez,A.M.,et al, 2001
Risk Factors for Sever Hemorrhagic Transformation in Ischemic Stroke Patients Treated with Recombinant Tissue Plasminogen Activator
Stroke 32:438-441, Larrue,V.,et al, 2001
Combined Intraarterial/Intravenous Thrombolysis for Acute Ischemic Stroke
AJNR 22:352-358, Keris,V.,et al, 2001
Deterioration Following Improvement with tPA Therapy: Carotid Thrombosis and Reocclusion
Neurol 56:568-570, Burgin,W.S. &Alexandrov,A.V., 2001
Clinical Deterioration Following Improvement in the NINDS rt-PA Stroke Trial
Stroke 32:661-668, Grotta,J.C.,et al, 2001
Most Commonly Asked Questions About Intra-arterial Thrombolysis
The Neurologist 7:127-131, Wechsler,L.R., 2001
Utilization of Intravenous Tissue-Type Plasminogen Activator for Ischemic Stroke at Academic Medical Centers
Stroke 32:1061-1068, Claiborne Johnston,S.,et al, 2001
Intravenous tPA for Ischemic Stroke Team Performance Over Time, Safety, and Efficacy in a Single-Center, 2-Year Experience
Stroke 32:1074-1078, Koennecke,H.,et al, 2001
Community Use of Intravenous Tissue Plasminogen Activator for Acute Stroke
Stroke 32:861-865, Katzan,I.L.,et al, 2001
Why Are Stroke Patients Excluded from TPA Therapy?
Neurol 56:1015-1020, Barber,P.A.,et al, 2001